IGF2BP2, as an N6- methyladenosine (m6A) reader, has been reported to be able to directly bind to and stabilize GLUT1 mRNA in pancreatic ductal adenocarcinoma and CRC [18]. This evidence concerns the gene SLC2A1 and colorectal carcinoma.